Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes
Open Access
- 2 May 2011
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 208 (5), 1083-1092
- https://doi.org/10.1084/jem.20092277
Abstract
Lymphangiogenesis plays an important role in tumor metastasis and transplant outcome. Here, we show that thrombospondin-1 (TSP-1), a multifunctional extracellular matrix protein and naturally occurring inhibitor of angiogenesis inhibits lymphangiogenesis in mice. Compared with wild-type mice, 6-mo-old TSP-1–deficient mice develop increased spontaneous corneal lymphangiogenesis. Similarly, in a model of inflammation-induced corneal neovascularization, young TSP-1–deficient mice develop exacerbated lymphangiogenesis, which can be reversed by topical application of recombinant human TSP-1. Such increased corneal lymphangiogenesis is also detected in mice lacking CD36, a receptor for TSP-1. In these mice, repopulation of corneal macrophages with predominantly WT mice via bone marrow reconstitution ameliorates their prolymphangiogenic phenotype. In vitro, exposure of WT macrophages to TSP-1 suppresses expression of lymphangiogenic factors vascular endothelial growth factor (VEGF)-C and VEGF-D, but not of a primarily hemangiogenic factor VEGF-A. Inhibition of VEGF-C is not detected in the absence or blockade of CD36. These findings suggest that TSP-1, by ligating CD36 on monocytic cells, acts as an endogenous inhibitor of lymphangiogenesis.Keywords
This publication has 56 references indexed in Scilit:
- Sjögren’s Syndrome-Like Ocular Surface Disease in Thrombospondin-1 Deficient MiceThe American Journal of Pathology, 2009
- Blocking the path of lymphatic vesselsNature Medicine, 2009
- Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthNature Medicine, 2009
- Silencing CD36 gene expression results in the inhibition of latent-TGF-β1 activation and suppression of silica-induced lung fibrosis in the ratRespiratory Research, 2009
- ‘Chimeric’ Grafts Assembled from Multiple Allodisparate Donors Enjoy Enhanced Transplant SurvivalAmerican Journal of Transplantation, 2009
- Thrombospondin 1 Promotes Tumor Macrophage Recruitment and Enhances Tumor Cell Cytotoxicity of Differentiated U937 CellsCancer Research, 2008
- Thrombospondin-based antiangiogenic therapyMicrovascular Research, 2007
- Decreased Macrophage Number and Activation Lead to Reduced Lymphatic Vessel Formation and Contribute to Impaired Diabetic Wound HealingThe American Journal of Pathology, 2007
- Corneal avascularity is due to soluble VEGF receptor-1Nature, 2006
- Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and visionProceedings of the National Academy of Sciences of the United States of America, 2006